Robert B. Ford serves as the Chairman of the Board and Chief Executive Officer at Abbott Laboratories, a global healthcare company that develops and manufactures medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals. Ford joined Abbott in 1996 and has held various leadership positions within the organization, showcasing his dedication and commitment to the company's success. His journey at Abbott began in the finance department, and he gradually ascended through the ranks, taking on roles of increasing responsibility in different business segments, including diagnostics, diabetes care, and medical devices. Throughout his tenure at Abbott, Ford has been instrumental in driving the company's growth and innovation. Under his leadership, Abbott has expanded its global presence and diversified its product portfolio, focusing on developing cutting-edge solutions to address unmet medical needs. One of his notable achievements was leading the successful acquisition of St. Jude Medical in 2017, which significantly strengthened Abbott's position in the medical device market, particularly in the areas of cardiovascular and neuromodulation technologies. Ford's strategic vision and ability to navigate complex market dynamics have been key factors in Abbott's continued success and growth. As Chairman and CEO, Ford is responsible for overseeing the overall direction and performance of Abbott Laboratories. He works closely with the board of directors and executive team to set the company's strategic priorities, ensuring that Abbott remains at the forefront of the healthcare industry. Ford's leadership style emphasizes collaboration, innovation, and a strong commitment to improving the lives of patients worldwide. His extensive experience within the company, combined with his deep understanding of the healthcare landscape, positions him well to guide Abbott through the challenges and opportunities of the future.